EWML
ZNTL icon

Eiger Wealth Management, LLC’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Eiger Wealth Management, LLC’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$319K Buy
115,112
+29,095
+34% +$117K 6.9% 4
2026
Q2 		$417K Hold
86,017
– – 13.07% 3
2026
Q1 		$201K Hold
86,017
– – 6.61% 6
2025
Q4 		$116K Buy
+86,017
New +$125K 3.08% 14

Other funds holding ZNTL

Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
DLK Investment Management
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
Investment Research & Advisory Group
Investment Research & Advisory Group Atlanta, Georgia $337M AUM 19.8% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
SJS Investment Consulting
SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Eiger Wealth Management, LLC's ZNTL Position: Q3 2026 in Review

Eiger Wealth Management, LLC increased its Zentalis Pharmaceuticals (ZNTL) stake by 34% in Q3 2026, buying an estimated $117K and bringing the position to 115,112 shares worth $319K. The position accounts for 6.9% of the portfolio, ranked #4.

Eiger Wealth Management, LLC first reported a position in ZNTL in Q4 2025 and has held it in 4 quarters since. The position peaked at $417K in Q2 2026. 20 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

  • Eiger Wealth Management, LLC held 115,112 shares of Zentalis Pharmaceuticals worth $319K as of Q3 2026.
  • Eiger Wealth Management, LLC bought 29,095 Zentalis Pharmaceuticals shares in Q3 2026, an estimated $117K.
  • Zentalis Pharmaceuticals made up 6.9% of Eiger Wealth Management, LLC's portfolio in Q3 2026, its #4 holding.
  • Eiger Wealth Management, LLC first reported a position in Zentalis Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Eiger Wealth Management, LLC's Zentalis Pharmaceuticals position peaked at $417K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on Eiger Wealth Management, LLC's 13F filing for Q3 2026, filed 3 Nov 2026.